When COVID-19 first swept across the U.S., people with end-stage kidney disease—those who rely on dialysis to survive—were among the most vulnerable. A new look at national data estimates that between 7,000 and 10,300 more of these patients died during the first seven months of the pandemic than would have been expected in a normal year. That translates to roughly 9 to 13 extra deaths for every 1,000 people in this high-risk group. This study didn't try to pinpoint the exact causes of these excess deaths, which could include COVID-19 itself, disruptions to medical care, or other pandemic-related factors. It simply measures the gap between what happened and what was expected. The analysis covers a massive group—nearly 800,000 U.S. patients—but it's an observational snapshot, not a controlled experiment. It tells us the scale of the loss during that frightening period, but it can't prove what specifically drove it.
How many more dialysis patients died during the first COVID-19 wave?
Photo by National Cancer Institute / Unsplash
What this means for you:
The pandemic's first wave brought a sharp rise in deaths among people on dialysis. More on End Stage Renal Disease
Machine learning model identifies RLS in ESRD patients with AUC 0.791 Machine learning model helps identify restless legs in dialysis patients
Frontiers · Apr 29, 2026
Single-centre observational study on hemodialysis duration and outcomes in end-stage renal disease. Shorter Dialysis Sessions May Offer Better Quality of Life for Older Patients
medRxiv · Apr 22, 2026
Meta-analysis of nutrition education in adult dialysis patients shows improved knowledge and quality of life. Simple Diet Lessons Help Dialysis Patients Feel Better
· Apr 22, 2026
Cryopreserved venous allografts increased cold ischemia time in living-donor kidney transplant recipients. Does stretching a kidney vein during transplant add dangerous wait time for the organ?
Frontiers · Apr 16, 2026